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maternal	 thyroid	 hormone	 insufficiency	 during	 pregnancy	 and	neurodevelopmental	
disorders	in	children.	We	also	sought	to	assess	whether	levothyroxine	treatment	for	
maternal	thyroid	hormone	insufficiency	improves	child	neurodevelopment	outcomes.







































results,5,6	 and	 there	 remains	 an	 uncertainty	 whether	 levothyroxine	




We	 therefore	 conducted	 a	 systematic	 review	 and	meta-	analysis	








A	 systematic	 review	was	 conducted	 according	 to	 the	 best	 practice	
guidelines	recommended	by	the	Centre	for	Research	Dissemination9 





developed	 for	 MEDLINE	 (Appendix	 S1)	 and	 adapted	 as	 appropri-
ate	 for	 the	 other	 searched	 databases:	 EMBASE,	 PsycInfo,	 CINAHL,	
AMED,	 the	British	Nursing	 Index,	 the	Cochrane	Central	Register	of	
Controlled	Trials,	Scopus,	Web	of	Science,	GreyLit,	Grey	Source	and	
Open	Grey	(WT).	MEDLINE,	EMBASE	and	PsychInfo	were	searched	





tion	 to	 February	 2016,	with	 an	 update	 search	 conducted	 in	March	
2017.	 No	 study	 design	 or	 language	 restrictions	 were	 imposed,	 but	
case-	reports,	case-	series,	reviews,	editorials	and	commentaries	were	
excluded.
The	 search	 strategy	 consisted	of	3	blocks	of	 terms,	 those	 for	 (i)	








Autistica,	 Autism	 Speaks,	 Dame	 Shirley	 Foundation,	 International	
Society	 for	Autism	Research,	 Simons	 Foundation,	Waterloo	 founda-
tion,	 National	 Autistic	 Society,	 British	 Thyroid	 Foundation,	 British	




Observational	 studies	 were	 included	 if	 they	 investigated	 the	 asso-
ciation	 of	 maternal	 thyroid	 hormone	 insufficiency	 (including	 overt	
hypothyroidism,	 subclinical	 hypothyroidism	 and	 maternal	 hypothy-









ADHD	or	 autism	 studies	where	 a	diagnosis	or	 a	 validated	 scale	 for	
measuring	 these	 conditions	were	 reported	 as	 an	 outcome	measure	
in	the	offspring.	We	excluded	studies	that	focussed	on	psychomotor	
development	 rather	 than	 neuropsychological	 development.	 Studies	








K E Y W O R D S
autism,	hypothyroxinaemia,	intelligent	quotient,	pregnancy,	subclinical	hypothyroidism,	thyroid
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2.3 | Study selection
The	 search	 results	 were	 uploaded	 to	 reference	 management	 soft-
ware	(Endnote	X7).	Titles	and	abstracts	were	screened	for	relevance	
independently	 by	 2	 reviewers	 (WT	 and	 JTC	 or	GB),	with	 any	 disa-






















































































information	 in	 a	 form	 that	 would	 allow	 straightforward	 conversion	
into	odds	ratios:	for	example,	2	studies29,30	provided	linear	regression	






but	 using	 continuous	predictors	 (n	=	1)39	 and	 reporting	psychomotor	
outcomes	 only	 (n	=	3).19,24,42	 Details	 on	 why	 studies	 were	 excluded	
from	the	meta-	analysis	are	shown	in	Table	S5.
3.4 | Association between maternal thyroid hormone 
insufficiency and indicators of intellectual disability
3.4.1 | Overt hypothyroidism
There	were	 inadequate	 data	 to	 perform	 a	meta-	analysis	 on	 the	 asso-
ciation	between	overt	hypothyroidism	and	indicators	of	intellectual	dis-
ability.	Two	studies	claimed	to	measure	overt	hypothyroidism,2,48 but in 
F IGURE  1 The	PRISMA	diagram	showing	search	strategy	and	exclusion	criteria	at	each	step





Eleven	 studies	were	 included	 in	 the	meta-	analysis	 (Figure	2).	There	
was	evidence	of	an	effect	of	maternal	subclinical	hypothyroidism	on	












with	 indicators	 of	 intellectual	 disability,	 and	 the	 magnitude	 of	 the	
point	estimate	was	 reduced	 (OR	1.11,	95%	CI	0.66	 to	1.88,	P	=	.7)	
(Figure	S5).	The	5	studies	are	not	included	in	the	subclinical	hypothy-
roidism	 and	 risk	 of	 intellectual	 impairment	meta-	analysis26,27,29,35,39 
found	 no	 association	 between	maternal	 subclinical	 hypothyroidism	
and	impaired	neuropsychological	development	in	children.
3.4.3 | Hypothyroxinaemia






between	maternal	 hypothyroxinaemia	 and	 impaired	 neurodevelop-
ment	 in	children.	Our	sensitivity	analyses	showed	that	 the	method	
used	 to	 convert	 continuous	measures	 to	 odds	 ratios	 had	 little	 im-
pact	on	interpretation	(Table	S6).	When	only	studies	reporting	odds	
ratios	 (4	 studies)	were	 included	 in	 the	meta-	analysis,	maternal	 hy-
pothyroxinaemia	was	not	significantly	associated	with	 indicators	of	
intellectual	 disability,	 though	 the	 magnitude	 of	 the	 point	 estimate	






3.5 | Association between maternal thyroid hormone 
insufficiency and autism
Three	studies	investigated	the	link	between	maternal	overt	hypothy-
roidism	 and	 autism,	 3	 studies	 investigated	 the	 link	 between	mater-
nal	subclinical	hypothyroidism	and	autism,	and	2	studies	investigated	
the	 link	between	maternal	hypothyroxinaemia	and	autism.	Of	 the	3	
studies	 that	 investigated	 the	 link	between	maternal	 overt	 hypothy-
roidism	and	autism,	2	studies37,50	are	based	on	overt	hypothyroidism	
status	on	hospital	records,	whilst	one	study40	measured	the	mother’s	
thyroid	 hormones	 directly.	 As	 there	was	 no	 information	 on	 thyroid	
hormone	 levels	on	 the	mothers	with	hypothyroidism	based	on	hos-














NOTE: Weights are from random-effects analysis
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meta-	analysis,	 thus	no	meta-	analysis	 could	 take	place.	None	of	 the	









3.6 | Association between maternal 
hypothyroidism and ADHD







ratio	1.10,	 95%	CI	0.98	 to	1.25).37	Our	meta-	analysis	 found	no	 as-
sociation	between	maternal	subclinical	hypothyroidism	and	ADHD	in	
children	(OR	1.58,	95%	CI	0.5	to	5.0,	P	=	.44)	(Figure	S3)	or	between	











NOTE: Weights are from random-effects analysis
.
.
Overall  (I2 = 0.0%, P = .865)
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F IGURE  3 Meta-	analysis	of	studies	








NOTE: Weights are from random-effects analysis
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3.7 | Effect of levothyroxine treatment in maternal 









with	 hypothyroxinaemia	 treated	with	 levothyroxine	 and	 those	who	
were	not	treated	(OR	0.88,	95%	CI	0.67	to	1.17,	P	=	.38)	(Figure	4).
4  | DISCUSSION
This	 systematic	 review	 and	 meta-	analysis	 show	 an	 association	 be-










analyses	 on	 the	 association	 between	 maternal	 thyroid	 hormone	
insufficiency	 and	 neurodevelopmental	 disorders	 in	 offspring	 were	
published.52,53	Compared	 to	 these	 previous	 systematic	 reviews,	 our	
study	had	a	wider	scope	as	we	analysed	multiple	neurodevelopmen-
tal	 disorders	 (including	 autism	 and	ADHD)	 in	 addition	 to	 indicators	
of	 intellectual	 disability,	 and	 performed	 meta-	analysis	 on	 RCTs	 of	











vious	 systematic	 reviews,52,53	 for	 example,	 Fan	 and	 colleagues52 in-
cluded	only	2	studies	in	their	subclinical	hypothyroidism	meta-	analysis	
compared	 to	 the	11	studies	 included	 in	our	meta-	analysis.	Wang	et	
al53	did	not	assess	 the	association	between	subclinical	hypothyroid-
ism	and	 indicators	of	 intellectual	 disability.	 In	 a	previous	 systematic	
review,	Chan	and	Boelaert54	analysed	the	effects	of	subclinical	hypo-
thyroidism	and	hypothyroxinaemia	on	obstetric	outcomes;	however,	
the	 study	 did	 not	 include	meta-	analysis	 of	 child	 neurodevelopment	
outcomes.
The	 association	 between	 mild	 maternal	 thyroid	 hormone	 insuf-
ficiency	 (subclinical	 hypothyroidism	 and	 hypothyroxinaemia)	 and	
neurodevelopment	 in	 offspring	 found	 in	 this	 systematic	 review	 is	
biologically	 plausible.	 Thyroid	 hormones	 have	 an	 important	 impact	




brain	 cells	 (particularly	Cajal-	Retzius	 cells	 in	 the	 cerebellum)	 to	pro-
duce	Reelin,	which	in	turn	acts	as	a	scaffold	for	migrating	neurons.55 
This	is	a	major	part	in	the	formation	of	the	cerebellum,56	the	corpus	
callosum57	and	the	cerebral	cortex,55	areas	 in	 the	brain	 that	are	 im-
portant	in	motor58,59	and	cognitive	function.60	Thyroid	hormone	is	also	
important	 in	 the	process	of	white	matter	 formation,	 stimulating	 the	








hormone	 receptor	which	 is	 expressed	much	 later	 in	development.65 
Even	 though	maternal	 thyroid	hormone	 insufficiency	 in	early	gesta-
tion	(before	the	foetal	thyroid	gland	becomes	functional)	is	potentially	






This	 systematic	 review	 found	 no	 association	 between	 maternal	
thyroid	hormone	 insufficiency	 and	offspring	 risk	of	ADHD	while	 its	
impact	on	the	offspring	risk	of	autism	was	unclear.	As	some	research-
ers	have	suggested	autism	appears	to	be	linked	to	a	lack	of	neuronal	
migration,66	 and	 some	 studies	 suggest	ADHD	 is	 linked	 to	 a	 lack	 of	
functional	connectivity67	(hinting	at	a	lack	of	white	matter	formation),	







We	were	 unable	 to	 demonstrate	 evidence	 of	 a	 beneficial	 effect	
of	 levothyroxine	 treatment	 in	 pregnant	 women	 with	 mild	 thyroid	

































systematic	 review	does	not	 support	 the	Associations’	 recommenda-
tions69,70	of	treating	maternal	subclinical	hypothyroidism	in	pregnancy	















els	 rather	 than	 the	combination	of	TSH	and	 fT4	 levels.	Therefore,	
although	we	 included	 these	as	 subclinical	hypothyroidism	studies,	
it	 is	possible	that	a	small	number	of	subjects	with	high	TSH	 levels	




TSH	 levels	 in	 addition	 to	 low	 fT4	 levels,	 thus	 constituting	 overt	
hypothyroidism,	 though	 they	were	 in	 the	minority	 and	unlikely	 to	
have	impacted	on	the	overall	results.	Thirdly,	5	observational	stud-
ies	also	explicitly	included	participants	being	treated	with	levothy-
roxine	 for	 hypothyroidism	within	 the	 case	 group,2,5,23,37,50	making	
the	 direct	 comparison	with	 other	 studies	where	 the	 treatment	 of	
participants	is	unclear	difficult.	Also,	different	studies	had	different	
exclusion	criteria,	 for	example	2	studies	only	 included	participants	





ence	 in	 interpretation	between	 the	2	 results	generated.	However,	
we		excluded	5	studies	from	meta-	analysis	as	it	was	not	possible	to	
	convert	their	results	to	odds	ratios.





mone	 insufficiency,	 including	maternal	 hypothyroxinaemia	 and	 sub-
clinical	 hypothyroidism,	 improves	 neurodevelopmental	 outcomes	 in	
children.
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